ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 10 filers reported holding ENZON PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $72,000 | -31.4% | 153,800 | 0.0% | 0.00% | -50.0% |
Q4 2015 | $105,000 | -29.5% | 153,800 | 0.0% | 0.00% | -33.3% |
Q3 2015 | $149,000 | +198.0% | 153,800 | +271.5% | 0.00% | +200.0% |
Q2 2015 | $50,000 | -88.3% | 41,400 | -83.7% | 0.00% | -93.3% |
Q3 2013 | $427,000 | +65.5% | 254,200 | +96.7% | 0.02% | +50.0% |
Q2 2013 | $258,000 | – | 129,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ancora Advisors LLC | 50,000 | $20,000 | 0.00% |
MONARCH CAPITAL MANAGEMENT INC/ | 10,000 | $4,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 122,287 | $50,000 | 0.00% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 254,200 | $103,000 | 0.00% |
TUDOR INVESTMENT CORP ET AL | 47,998 | $19,000 | 0.00% |
O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 11,181 | $5,000 | 0.00% |
Kistler-Tiffany Companies, LLC | 825 | $0 | 0.00% |
Tradewinds Capital Management, LLC | 200 | $0 | 0.00% |
NEXT Financial Group, Inc | 60 | $0 | 0.00% |
CT Financial Advisors LLC | 2,000 | $810,000 | 0.00% |